key: cord-0078156-9tu54ugf
authors: Morin, Daniel P.
title: Meet Our Editorial Board Member
date: 2021-05-21
journal: Curr Cardiol Rev
DOI: 10.2174/1573403x1703210409094628
sha: 0285b0b4f769558f5961c239bf72446d6646da2f
doc_id: 78156
cord_uid: 9tu54ugf

nan

American College of Cardiology and the Heart Rhythm Society.

Dr. Morin's clinical interests are in device therapy for cardiac dysfunction (including cardiac resynchronization therapy) and treatment of cardiac arrhythmias via medical therapy and/or catheter ablation.

In addition to his clinical work, he heads an active team researching diverse subjects such as risk stratification for sudden cardiac arrest, new applications for cardiac resynchronization therapy, the effects of ablation on cardiac contractility and relationships between the environment and cardiac tachyarrhythmias. He has published peer-reviewed scientific papers published in prestigious journals such as New England Journal of Medicine, Journal of the American College of Cardiology, European Journal of Cardiology, and Heart Rhythm. Dr. Morin is an associate editor of several medical journals and served as the inaugural online editor of the journal Heart Rhythm for five years.

In 2020, Dr. Morin was promoted to the academic title of Professor at University of Queensland -Ochsner Clinical School.

Amiodarone in the COVID-19 era: Treatment for symptomatic patients only, or drug to prevent infection?

Dimensionless index of the mitral valve for evaluation of degenerative mitral stenosis

Positron emission tomography absolute stress myocardial blood flow for risk stratification in nonischemic cardiomyopathy

Impact of wearable cardioverter-defibrillator compliance on outcomes in the VEST trial: As-treated and per-protocol analyses

Class 1C antiarrhythmic drugs in atrial fibrillation and coronary artery disease